Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis

BACKGROUND: Cognitive impairment affects many patients with multiple sclerosis (MS). NeuroTrax, a computerized cognitive screen that can be administered during routine clinical care, provides a consistent, validated, objective cognitive profile measure with a global cognitive score (GCS) and seven i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gudesblatt, Mark, Wissemann, Karl, Zarif, Myassar, Bumstead, Barbara, Fafard, Lori, Wilken, Jeffrey, Blitz, Karen, Buhse, Marijean, Santra, Sourav, Hotermans, Christophe, Lee, Lily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280854/
https://www.ncbi.nlm.nih.gov/pubmed/30143944
http://dx.doi.org/10.1007/s40263-018-0553-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280854/
https://www.ncbi.nlm.nih.gov/pubmed/30143944
http://dx.doi.org/10.1007/s40263-018-0553-1

Ejemplares similares